C1q binding and complement activation by capsular and cell wall components of S. pneumoniae type XIX

Area of Science:

• Immunology
• Microbiology
• Biochemistry

Background:

• Streptococcus pneumoniae is a major human pathogen.
• The complement system is a critical component of innate immunity.
• Understanding pathogen-complement interactions is crucial for developing novel therapeutics.

Purpose of the Study:

• To investigate the direct binding of Streptococcus pneumoniae cell wall components to the complement protein C1q.
• To determine the capacity of these components to activate the classical and alternative complement pathways.

Main Methods:

• C1q deviation tests were performed using purified cell walls, teichoic acid, and residual cell walls from S. pneumoniae type XIX.
• Complement C1 activation was assessed in normal human serum and hypo-gamma-globulinemic serum.
• Alternative pathway activation was evaluated in C1q-deficient serum and Mg2+-EGTA chelated normal serum.

Main Results:

• Purified cell wall components, especially teichoic acid, demonstrated antibody-independent C1q binding.
• Specific capsular substances did not exhibit C1q binding.
• All tested substances induced C1 activation in normal serum but not in hypo-gamma-globulinemic serum.
• Teichoic acid effectively activated the alternative complement pathway.

Conclusions:

• Teichoic acid from S. pneumoniae exhibits significant C1q binding capacity and activates the alternative complement pathway.
• The classical complement pathway activation by these components is antibody-dependent.
• These findings elucidate the role of bacterial cell wall components in initiating complement-mediated immune responses.